
Catecholamines and Schizophrenia
- 1st Edition - January 1, 1975
 - Latest edition
 - Editors: Steven W. Matthysse, Seymour S. Kety
 - Language: English
 
Catecholamines and Schizophrenia reviews research linking catecholamines to schizophrenia. Topics include the relationship between stereotyped behavior and amphetamine psychosis,… Read more

Catecholamines and Schizophrenia reviews research linking catecholamines to schizophrenia. Topics include the relationship between stereotyped behavior and amphetamine psychosis, between antipsychotic drugs and catecholamine synapses, and between biogenic amines and behavior. The chemical neuropathology of schizophrenia, enzymology and regulation of catecholamine enzymes, and advances in histochemical technologies used in neurochemical pathology are also covered.  This book consists of 47 chapters organized into six sections. After giving an overview of the pharmacology and physiology of stereotyped behavior, this book discusses the behavioral and biochemical aspects of amphetamine psychosis; stereoselective features of catecholamine disposition and their behavioral implications; and the effects of amphetamines on catecholamine metabolism. A two-factor theory of schizophrenia is also presented. The chapters that follow focus on the role of monoamine oxidase in schizophrenia and other behavioral disorders; the chemical pathology of schizophrenia; genetic control of biogenic amines; and dopamine-beta-hydroxylase.  This book will be of value to students, researchers, and practitioners in fields ranging from neuropharmacology and physiology to biology, biochemistry, psychiatry, and psychology.
I. Stereotyped Behavior and Amphetamine PsychosisPrologue     Pharmacology and Physiology of Stereotyped Behavior          Discussion     Amphetamine Phychosis: Behavioral and Biochemical Aspects     A Two Factor Theory of Schizophrenia     Stereoselective Features of Catecholamine Disposition and Their Behavioral Implications     Effects of Amphetamines on the Metabolism of Catecholamines in the Rat Brain     A Mass Fragmentographic Study of Amphetamine and Metabolites in rat Brain          DiscussionII. Antipsychotic Drugs and Catecholamine Synapses     Antipsychotic Drugs and Catecholamine Synapses     Dose Equivalence of the Antipsychotic Drugs     Brief Communications:     Catecholamines and Antipsychotic Drugs in Periodic Catatonia     A Pilot Study of Pimozide in Schizophrenia     Dopaminergic Blocking Effects of Antipsychotic Drugs     Mass Fragmentometric Determination of Homovanillic Acid in Lumbar Cerebrospinal Fluid of Schizophrenic Patients during Treatment with Antipsychotic Drugs     New Developments in the Study of the Mechanism of Action of Neuroleptics and Amphetamine     Biochemical Characterization of the Dopamine Receptor in the Mammalian Caudate Nucleus     Antischizophrenic Drugs: Affinity for Muscarinic Cholinergic Receptor Sites in the Brain Predicts Extrapyramidal Effects     Antipsychotic Drugs and Catecholamine Synapses. Summary of the Session          Discussion     Dopamine and the Pharmacology of Schizophrenia: The State of the EvidenceIII. Biogenic Amines and Behavior     Self-stimulation Reward Pathways: Norepinephrine vs Dopamine     Relationship of Biogenic Amines to Behavior     Role of Dopamine and Norepinephrine in the Chemistry of Reward     Consideration of some Problems Encountered in Relating Specific Neurotransmitters to Specific Behaviors or Disease     Central Dopamine Neurons and Sensory Processing     Central Catecholamine Neurons, Behavior and Neuroleptic Drugs: An Analysis to Understand the Involvement of Catecholamines in Schizophrenia     Brain Dopamine and Behavior. A Critical Analysis of the Relationship between Dopamine Antagonism and Therapeutic Efficacy of Neuroleptic Drugs     The Role of Adaptive Regulation in the Pathophysiology of Psychiatric Disease          Discussion     Behavioral Effects of Central Catecholamines. Concluding RemarksIV. Chemical Neuropathology of Schizophrenia     Post-mortem Measurement of Enzymes in Human Brain: Evidence of a Central Noradrenergic Deficit in Schizophrenia     Post-mortem Fluorescence Histochemistry of Monoamine Neuron Systems in the Human Brain: A New Approach in the Search for a Neuropathology of Schizophrenia     Studies on Dopamines-Hydroxylase in Mental Disorders     Behavioral Effects of a New Dopamine-β-Hydroxylase Inhibitor (Fusaric Acid) in Man          Discussion     Monoamine Oxidase in Schizophrenia and Other Behavioral Disorders     Some Remarks Concerning the Possible Role of Brain Monoamines (Dopamine, Noradrenaline, Serotonin) in Mental Disorders     Analysis of Glutamate Decarboxylase in Post-mortem Brain Tissue in Huntington's Chorea     A New Hypothesis on the Origin of Schizophrenia     N5.1-Methylenetetrahydrofolate Reductase Deficiency and Schizophrenia: A Working Hypothesis          Discussion     Problems of Interpretation in the Chemical Pathology of SchizophreniaV. Recent Advances in Historical Technology     Introduction: Quantitative Histochemistry     Recent Developments in Monoamine Histochemistry     Dopamine Histofluorescence in Post-mortem Specimens of Human and Rat Striatum     Localization of the Noradrenergic Nervous System in Human Brain     Enzymatic-Isotopic Micromethods for the Measurement of Biogenic Amines in Brain Tissue and Body Fluids     Genetic Control of Biogenic Amines and the Possibilities Offered by New Microanalytical Techniques for the Investigation of Human Cerebrospinal Fluid     Multiple Detection: A New Tool for Neurochemistry and Biological Psychiatry          DiscussionVI. Enzymology and Regulation of Catecholamine Enzymes     Dopamine-Beta-Hydroxylase     Immunological Localization of Dopamine-Beta-Hydroxylase on the Chromaffin Granule MembraneBrief Communication:     The Subunit Structure and Carbohydrate Content of Bovine Adrenal Dopamine-β-Hydroxylase          Discussion     Introductory Remarks on Monoamine Oxidase     On the Physico-Chemical Characterization of Monoamine Oxidase (MAO) as a Basis for the Study of its Role in Physiological and Pathological Processes          Discussion     Regulation of Catecholamine-Synthesizing Enzymes     The Regulation of the Noradrenergic Neuron     Genetic Differences in Mechanisms Involving NeuroregulatorsBrief Communication:     Possible Role of Catecholamines (CH) in the Regulation of Adrenal Tyrosine Hydroxylase (TH)     DiscussionEpilogueContributorsSubject Index
- Edition: 1
 - Latest edition
 - Published: January 1, 1975
 - Language: English
 
Read Catecholamines and Schizophrenia on ScienceDirect